Frost and Sullivan award

InSightec’s ExAblate® 2000, the first U.S. Food and Drug Administration (FDA) approved Magnetic Resonance-guided Focused Ultrasound (MRgFUS) technology for the non-invasive treatment of uterine fibroids has once again been recognized for technology achievement. Frost & Sullivan, the international growth consultant, has awarded InSightec its 2005 Technical Innovation Award in the field of non-invasive medical devices for outstanding industry achievement.